Pharmaceutical Raw Material Ceftriaxone Sodium CAS 74578-69-1
GMP ISO 10 Inquiries
74578-69-1
0%
Foil Bag, Box, Drum
2022-12-31
Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
Pharmaceutical raw material ceftriaxone sodium CAS 74578-69-1
Name: Ceftriaxone sodium
CAS No.: 74578-69-1
Molecular formula: C18H19N8NaO7S3
Molecular weight: 578.57
Pure active ingredient: Assay mm. 99 %
Appearance: White powder
Solubility:Freely soluble in water.
Ceftriaxone Sodium as a semi-synthetic third-generation cephalosporins, for most Gram-positive bacteria and-negative bacteria have strong antibacterial activity, antibacterial spectrum, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, bacterial intestinal gas production , Proteus, and Staphylococcus aureus meningitis is so. The drug on β-lactamase stability.
Function
The main clinical infection for susceptible strains of meningitis, pneumonia, skin and soft tissue infections, peritonitis, urinary tract infections, gonorrhea, liver and gallbladder infection, surgical trauma, sepsis, and genital infections. As a treatment for gonorrhea has been first-line drugs.
Application
Ceftriaxone injection is often used (in combination, but not direct, with macrolide and/or aminoglycoside antibiotics) for the treatment of community-acquired or mild to moderate health care-associated pneumonia. It is also a choice drug for treatment of bacterial meningitis. In pediatrics, it is commonly used in febrile infants between 4 and 8 weeks of age who are admitted to the hospital to exclude sepsis.
CertificatesBasic Info-
Product Name:
Ceftriaxone sodium
Other Name:5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-,sodium salt (1:2),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-,disodium salt,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-,disodium salt,(6R,7R)-;Ro 13-9904;Ceftriaxone sodium;Rocephin;Cephtriaxone;Cefatriaxone;X 13-9904;Ceftriaxone disodium;Longaceph;Ceftriaxone disodium salt;Lendacin;Disodium ceftriaxone;Tartriakson;Ceroneed;Acantex;Monocef;Oframax;Sefirom;Cefotrix;Cefexone;Aventriax;Mesporin;Rochephin;195263-08-2
CAS No.:74578-69-1
Molecular Formula:C18H18N8O7S3.2Na
InChIKeys:InChIKey=VUGBLGCUPUUDOI-BBJOQENWSA-N
Molecular Weight:554.58
Exact Mass:598.009949
EC Number:277-930-0
DSSTox ID:DTXSID5045887
HScode:3004909090
Categories:
Characteristics-
PSA:
296.63000
XLogP3:-2.03600
Hazard IdentificationClassification of the substance or mixture
Skin sensitization, Category 1
Respiratory sensitization, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H317 May cause an allergic skin reaction
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled
Precautionary statement(s) Prevention P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P272 Contaminated work clothing should not be allowed out of the workplace.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P284 [In case of inadequate ventilation] wear respiratory protection.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P333+P317 If skin irritation or rash occurs: Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P342+P316 If experiencing respiratory symptoms: Get emergency medical help immediately.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin
-
Location:
I-City unit 3, South of Tangyan Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2015
-
Certifications:
HACCP,Halal,GMP,ISO
"> -
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Veterinary Drug Raw Material Ceftriaxone Sodium 99% Powder CAS 74578-69-1 EGC-Ceftriaxone Sodium Powder
300 KG Oct 31, 2023
Pakistan
Ceftriaxone Sodium
500 KG Jun 25, 2026
Pakistan
Ceftriaxone sodium sterile
100 KG Mar 5, 2026
Pakistan
CEFTRIAXONE SODIUM
100 KG Feb 4, 2026
Pakistan
Ceftriaxone sodium
200 KG Jun 4, 2025 
Uzbekistan
Ceftriaxone Sodium Sterile Powder
1000 KG Apr 9, 2025 
Bangladesh
Ceftriaxone Sodium
1.00 KG Jul 17, 2024
Pakistan
Ceftriaxone sodium
500 KG May 26, 2026 
India
CEFTRIAXONE SODIUM
180 KG Feb 10, 2025 
China
Ceftriaxone Sodium
30 MG Jan 24, 2025 Post an enquiry for this product
